Predictive Oncology Q3 loss of $2.3M; revenue down 49%; exploring strategic alternatives

Axe Compute Inc.

Loss from continuing ops of ~$2.3M on revenue of $345,686, down from $676,626 YoY.
EPS loss of $(0.36) vs $(0.68) in Q3 2023; cash fell to $3.1M from $8.7M at year end.
Board initiated process to evaluate strategic alternatives including sale or licensing to maximize shareholder value.
Implemented cost savings initiative reducing annualized cash burn by ~20%.
Raised $1.3M in July via warrant exercise of 958,117 warrants.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.